Physician

Aaron Cagle, FNP-BC

According to 2025 Medicare claims, Aaron Cagle, FNP-BC (NPI: 1881079283) practices nurse practitioner in the Hanford-Corcoran, CA market, with the plurality of this provider's patient population coming from Kings, CA. This provider's primary affiliated billing organization is EXCELLENCE MEDICAL GROUP INC (NPI: 1093074221; TIN: 454739793) and primary practice location at 93230-3813. Cagle is affiliated with the Aledade 91 CA MSSP Basic E (ACO ID: A5193), participating under the MSSP model.

Cagle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 402 traditional Medicare patients, billed 5,261 HCPCS/CPT codes, and received $185,698 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,015 prescription claims across 300 beneficiaries totaling $323,877 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 331 claims. Open Payments data shows 43 records totaling $1,024. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $28,911 to $185,698. Similarly, Part D prescription costs have risen steadily, from $8,394 to $323,877. For DME billing, reported payments moved sharply higher in recent years, from $1,083 to $63,182.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	200	782	$28,911
2016	365	2,984	$95,386
2017	378	3,084	$94,978
2018	774	5,848	$173,909
2019	706	5,847	$151,098
2020	416	3,380	$83,761
2021	648	4,032	$136,178
2022	387	3,313	$116,715
2023	375	4,509	$168,763
2024	402	5,261	$185,698

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	91	224	$8,394
2016	284	1,219	$49,282
2017	268	2,131	$96,624
2018	577	4,286	$314,764
2019	533	4,939	$422,491
2020	550	4,983	$349,199
2021	637	4,715	$330,878
2022	270	3,248	$262,613
2023	268	4,021	$375,213
2024	300	4,015	$323,877

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	57	$1,622
2018	N/R	71	$9,653
2019	N/R	78	$9,728
2020	N/R	12	$8,833
2021	N/R	12	$9,067
2022	N/R	245	$37,925
2023	N/R	336	$48,016
2024	24	331	$45,816

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	232	572	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	325	780	$54
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	45	453	$41
96372	Injection of drug or substance under skin or into muscle	81	309	$9
81003	Automated urinalysis test	53	81	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	51	1,484	$50,395
Jardiance	Empagliflozin	65	2,670	$50,149
Eliquis	Apixaban	27	1,470	$26,980
Ozempic	Semaglutide	21	588	$20,265
Repatha Sureclick	Evolocumab	16	784	$15,231

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	13	53	$26,752
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$10,415
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	87	$5,890
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	33	$815
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	14	$669

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$1,024	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Cagle, FNP-BC?

Tedicare shows public-source Medicare data for Aaron Cagle, FNP-BC (NPI 1881079283), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Cagle, FNP-BC have ACO affiliation data?

Aaron Cagle, FNP-BC is shown with ACO affiliation data for Aledade 91 CA MSSP Basic E (MSSP, ACO ID A5193).

What billing organization is linked to Aaron Cagle, FNP-BC?

Aaron Cagle, FNP-BC is linked to EXCELLENCE MEDICAL GROUP INC (billing NPI 1093074221) in the available physician profile data.

Does Aaron Cagle, FNP-BC have Open Payments data?

Aaron Cagle, FNP-BC has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.